Pancreatic Cancer Research

ResearcherUniversidade de Santiago de CompostelaActive in the last 2 years

J. Enrique Domínguez‐Muñoz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8283-3185; OpenAlex author ID A5082719612, A5103227381. Sources: OpenAlex.

Their work

Papers
20 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
41
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 20

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study. Co-author DOI 10.1158/1055-9965.epi-25-1601↗
  3. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. Co-author DOI 10.1002/ijc.35397↗
  4. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  5. HLA-A*02:01allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of theHLAvariation in PDAC Co-author DOI 10.1101/2024.08.29.24312704↗
  6. Emergent endoscopic ultrasound-guided cholecystoduodenostomy does not prevent R0 resection in a pancreaticoduodenectomy for pancreatic cancer. Last author DOI 10.1007/s12328-021-01540-1↗
  7. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. Co-author DOI 10.1097/cej.0000000000000588↗
  8. Endoscopic Pancreatic Drainage Improves Exocrine Pancreatic Function in Patients With Unresectable Pancreatic Cancer: A Double-Blind, Prospective, Randomized, … Co-author DOI 10.1097/mpa.0000000000001817↗
  9. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Co-author DOI 10.1136/gutjnl-2019-319990↗
  10. Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer. First author DOI 10.1007/s12094-020-02350-6↗
  11. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Co-author DOI 10.1158/1055-9965.epi-19-1027↗
  12. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. Co-author DOI 10.1002/ijc.31866↗
  13. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Co-author DOI 10.1093/ije/dyx269↗
  14. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. Co-author DOI 10.1186/s12885-018-4439-x↗
  15. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk. Co-author DOI 10.1093/annonc/mdx167↗
  16. Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Co-author DOI 10.1136/gutjnl-2015-310442↗
  17. Biliary drainage in pancreatic cancer: The endoscopic retrograde cholangiopancreatography perspective. Co-author DOI 10.4103/eus.eus_79_17↗
  18. Early detection of pancreatic cancer in patients with intraductal papillary mucinous neoplasms: the pivotal role of endoscopic ultrasound First author DOI 10.1055/s-0033-1359176↗
  19. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and du… Last author DOI 10.4321/s1130-01082012000600006↗
  20. The actual management of early pancreatic cancer. Last author PMID 23207609↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Luis Muñoz‐Bellvís · 9 shared papers, 2017–2025 · strength 0.76
  2. Núria Malats · 9 shared papers, 2017–2025 · strength 0.76
  3. Alfredo Carrato · 9 shared papers, 2017–2025 · strength 0.76
  4. William Greenhalf · 9 shared papers, 2017–2025 · strength 0.76
  5. Jorg H. Kleeff · 9 shared papers, 2017–2025 · strength 0.76
  6. Tatjana Crnogorac‐Jurcevic · 9 shared papers, 2017–2025 · strength 0.76
  7. Thomas Mathias Gress · 9 shared papers, 2017–2025 · strength 0.76
  8. Francisco X. Real · 9 shared papers, 2017–2025 · strength 0.76
  9. Julio Iglesias‐García · 6 shared papers, 2012–2022 · strength 0.64
  10. Matthias J. Löhr · 8 shared papers, 2017–2025 · strength 0.62
  11. Rita Teresa Lawlor · 7 shared papers, 2017–2025 · strength 0.62
  12. Linda Sharp · 8 shared papers, 2017–2024 · strength 0.58
  13. Bo Kong · 8 shared papers, 2017–2024 · strength 0.58
  14. Aldo Scarpa · 8 shared papers, 2017–2024 · strength 0.58
  15. Eithne Costello · 8 shared papers, 2017–2024 · strength 0.58
  16. Christoph W. Michalski · 7 shared papers, 2017–2024 · strength 0.54
  17. Paulina Gómez-Rubio · 7 shared papers, 2017–2021 · strength 0.44
  18. Weimin Ye · 5 shared papers, 2018–2024 · strength 0.41
  19. Esther Molina‐Montes · 6 shared papers, 2017–2021 · strength 0.40
  20. José Lariño‐Noia · 3 shared papers, 2017–2022 · strength 0.38
  21. Alberto Langtry · 2 shared papers, 2024–2025 · strength 0.32
  22. Daniel de la Iglesia · 2 shared papers, 2021–2022 · strength 0.30
  23. Jingru Yu · 3 shared papers, 2019–2021 · strength 0.22
  24. Bilal Alashkar Alhamwe · 1 shared paper, 2025 · strength 0.18
  25. Jiangchuan He · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.